Cumulative dose-response curves for atracurium in patients with myasthenia gravis
β Scribed by Charles E. Smith; Francois Donati; David R. Bevan
- Publisher
- Springer-Verlag
- Year
- 1989
- Tongue
- French
- Weight
- 311 KB
- Volume
- 36
- Category
- Article
- ISSN
- 1496-8975
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Myasthenia gravis is a Bβcellβmediated autoimmune neuromuscular disorder characterized by weakness and fatigability of skeletal muscles. The underlying defect is an autoantibodyβmediated attack on the acetylcholine receptors (AchRs) at the neuromuscular junction. Rituximab is a genetica
## Abstract A 75βyearβold man with severe oculobulbar myasthenia gravis (MG) treated with acetylcholine esterase inhibitors (AChEIs) was found to have muscleβspecific tyrosine kinase (MuSK) antibodies. Neurophysiological examination displayed extra repetitive discharges after the compound motor act
CT plays an important role in the diagnosis and staging of musculoskeletal tumors, but MRI offers several significant advantages. MRI can provide superior soft tissue and marrow contrast and direct multiplanar images are routinely obtainable. Previous MRI studies have utilized low field strength m